Liabilities / Assets
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
Score unavailable
Liabilities-to-revenue requires both liabilities and revenue on this filing.
Net Margin
100th percentile
Higher net margin than 100% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
14th percentile
Faster asset growth than 14% of similar nonprofits.
Revenue Growth
Score unavailable
A valid growth rate could not be computed from the available filing history.
Balance Sheet
Assets
Down$262,063
Down $135,332 (-34%) from 2011
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2011
Revenue And Expenses
Revenue
Down-$114,748
Down $278,308 (-170%) from 2011
Expenses
Down$20,584
Down $1,087 (-5.0%) from 2011
Net Income
Down-$135,332
Down $277,221 (-195%) from 2011
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview
Mission
Biomedical research into neural degerative diseases
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990EZSummary only. Only limited summary data is available for this year.
- Assets
- $262,063
- Liabilities
- $0
- Net assets
- -
- Revenue
- -$114,748
- Expenses
- $20,584
- Net income
- -$135,332